Showing 2391-2400 of 2494 results for "".
- Quick Eye Test May Flag Unrecognized Brain Injuryhttps://modernod.com/news/quick-eye-test-may-flag-unrecognized-brain-injury/2477145/A quick, noninvasive, handheld device that detects changes in pupil size may offer rapid assessment of potential brain injury in young athletes who have sustained a high-impact hit to the head but who exhibit no obvious signs of brain injury, according to a
- Johnson & Johnson Vision Introduces Tecnis Toric II 1-Piece IOL as New Monofocal Option for Patients with Astigmatismhttps://modernod.com/news/johnson-johnson-vision-introduces-tecnis-toric-ii-1-piece-iol-as-new-monofocal-option-for-patients-with-astigmatism/2477134/Johnson & Johnson Vision announced the FDA approval and US launch of Tecnis Toric II 1-Piece IOL. This is the first product approved on the new Tecnis Toric II platform, which offers more surface texture and friction on the IOL haptics to hold an IOL in proper position within the eye, accordi
- AI Screening for Diabetic Retinopathy Moves to Retail Clinicshttps://modernod.com/news/ai-screening-for-diabetic-retinopathy-moves-to-retail-clinics/2477127/Retail health clinics have been part of the trend in making healthcare more convenient, and now another option is being offered—testing for diabetic retinopathy—according to a Medscape report. However, an ophthalmologist won’
- CooperVision Earns Global Impact Award for Rebate Donation Program Resulting in $800,000 Raised for Optometry Giving Sighthttps://modernod.com/news/coopervision-earns-global-impact-award-for-rebate-donation-program-resulting-in-800000-raised-for-optometry-giving-sight/2477119/CooperVision offers a contact lens rebate donation program that enables consumers to designate all or part of their rebates to be given to Optometry Giving Sight (OGS). Seven years after the launch of that program, CooperVision has been recognized by 360insights, the company’s rebate and incentiv
- Johnson & Johnson Vision Announces Availability of Acuvue Oasys with Transitions Light Intelligent Technology in the UKhttps://modernod.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-uk/2477102/Johnson & Johnson Vision announced the national availability of Acuvue Oasys with Transitions Light Intelligent Technology in the UK. The first-of-its-kind photochromic contact lens offers superior visual performance indoor and outdoor, day and night, according to a company news release.
- Bloomberg: Allergan CEO’s Best Career Decision Was Taking a ‘Huge’ Pay Cuthttps://modernod.com/news/bloomberg-allergan-ceos-best-career-decision-was-taking-a-huge-pay-cut/2477083/Allergan Chief Executive Officer Brent Saunders told Bloomberg News that one of the most important career moves he ev
- Regenxbio Exercises Option for Global License for Use of SCS Microinjector in AAV Gene Therapy Deliveryhttps://modernod.com/news/regenxbio-exercises-option-for-global-license-for-use-of-scs-microinjector-in-aav-gene-therapy-delivery/2477053/Clearside Biomedical announced that Regenxbio has exercised its option under the previously announced option and license agreement to license Clearside’s proprietary, in-office SCS Microinjector for the delivery of adeno-associated virus (AAV)-based therapeutics, including but not
- New Hope for Patients With Vision Loss at SAVIR-Center for Vision Restorationhttps://modernod.com/news/new-hope-for-patients-with-vision-loss-at-savir-center-for-vision-restoration/2477031/Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and
- Bausch + Lomb Introduces Preservision AREDS 2 Formula Minigel Eye Vitaminshttps://modernod.com/news/bausch-lomb-introduces-preservision-areds-2-formula-minigel-eye-vitamins/2477024/Bausch + Lomb announced the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision AREDS
- Sun Pharma Launches Cequa for the Treatment of Dry Eye Disease in the UShttps://modernod.com/news/sun-pharma-launches-cequa-for-the-treatment-of-dry-eye-disease-in-the-us/2477008/Sun Pharmaceutical announced that its dry eye drug Cequa (cyclosporine ophthalmic solution) 0.09% is now commercially available the United States. Cequa, which offers the highest concentration of cyclosporine for ophthalmic use approved by the FDA, is indicated to increase tear production in pati